Abstract
The objective of this study was to evaluate the possible prognostic significance of p53 protein overexpression and tumor angiogenesis (TA) in nasopharyngeal carcinoma (NPC) patients, together with other clinicopathological variables. Forty-two NPC patients were evaluated in relation to survival. Nuclear p53 overexpression in neoplastic and endothelial cells was detected by immunohistochemistry (IHC) with the monoclonal antibody DO-7 and the polyclonal antibody against factor VIII-related antigen, respectively. Thereafter, we evaluated p53 cases in order to determine their nuclear immunoreactivity from negative (-) to positive (+, ++, +++). In addition, microvessels were counted in the most active areas of tumor neovascularization or hotspots using an image computer analyzer (MicroImage). A Cox multiple regression survival analysis was used to determine the best prognostic indicators in NPC patients. As a result, tumor microvessel count, considered as a continuous variable, was the most important independent prognostic indicator in relation to survival (p = 0.0273), with a relative risk of death of 2,4399 [95% confidence interval = 1.1051 ; 5.3871] associated with the highest microvessel counts. Moreover, the only clinicopatholo...Continue Reading
References
Nov 7, 1992·Lancet·E R HorakA L Harris
Dec 16, 1992·Journal of the National Cancer Institute·N WeidnerG Gasparini
Jan 3, 1990·Journal of the National Cancer Institute·J Folkman
Jan 3, 1991·The New England Journal of Medicine·N WeidnerJ Folkman
Sep 30, 1993·International Journal of Cancer. Journal International Du Cancer·M ToiT Tominaga
Sep 1, 1994·The Journal of Pathology·G FontaniniG Bevilacqua
Nov 11, 1993·International Journal of Cancer. Journal International Du Cancer·G GaspariniP Bevilacqua
Apr 15, 1996·Cancer·D F RoychowdhuryN Weidner
Jun 1, 1997·The Laryngoscope·N B WoodJ S Coon
Jun 1, 1997·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·K Norrby
Jun 6, 1998·Clinica Chimica Acta; International Journal of Clinical Chemistry·F Vera-SempereC Morera
Jan 1, 1997·Journal of Cancer Research and Clinical Oncology·C N QianH L Lin
Jan 23, 1999·Pathology, Research and Practice·Y TatemotoT Kimura
Apr 30, 1999·Pathology, Research and Practice·C RakozyF H Sarkar
May 20, 1999·The Laryngoscope·N WakisakaI Nakanishi
Aug 17, 1999·Pathology, Research and Practice·A SantinelliI Bearzi
Feb 26, 2000·Carcinogenesis·R S Kerbel
Oct 18, 2000·Pathology Oncology Research : POR·L RubioF J Vera-Sempere
Dec 29, 2000·The Laryngoscope·H Guang-WuT Kosugi
Feb 24, 2001·The Laryngoscope·S EdströmC Young
Citations
Feb 15, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E P HuiA T C Chan
Apr 11, 2012·Cancer Letters·Yingxi MoMariko Murata
Mar 10, 2009·Pathology, Research and Practice·Zhi LiHui-Zhen Liang
Sep 28, 2010·Journal of Surgical Oncology·Bing LiaoBin Li
Dec 21, 2010·Histopathology·Ludmilla R SouzaAlfredo M B De Paula
Jun 20, 2013·Head & Neck·Min YuYuquan Wei
Jun 25, 2004·Clinical Oncology : a Journal of the Royal College of Radiologists·B WeynW Jacob
Apr 30, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Tieshan JiangMarco Mascini
Jan 29, 2010·Acta Oto-laryngologica·Gino MarioniStella Blandamura
Jun 30, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wan-Teck LimEng-Huat Tan
Nov 24, 2004·Pediatric Blood & Cancer·Gil Bar-SelaOfer Ben-Izhak